Adrenal Lymphocytic Infiltration and Adrenocortical Tumors in a Patient with 21-Hydroxylase Deficiency
- 8 April 1999
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (14) , 1121-1122
- https://doi.org/10.1056/nejm199904083401416
Abstract
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency results in deficient production of cortisol and aldosterone, chronic stimulation of the adrenal cortex by corticotropin, and overproduction of androgens. Cortisol-replacement therapy often fails to normalize corticotropin and androgen secretion, and high doses may be needed.1 Adrenocortical tumors, including cancers, are rare in patients with 21-hydroxylase deficiency but have been reported in patients with large adrenal glands and presumably inadequate cortisol therapy.2Keywords
This publication has 5 references indexed in Scilit:
- Aberrant Interleukin-1 Receptors in a Cortisol-Secreting Adrenal Adenoma Causing Cushing's SyndromeNew England Journal of Medicine, 1998
- New approaches to the treatment of congenital adrenal hyperplasiaPublished by American Medical Association (AMA) ,1997
- MHC class II expression--a new tool to assess dignity in adrenocortical tumoursJournal of Clinical Endocrinology & Metabolism, 1996
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Virilizing adrenocortical carcinoma. Development in a patient with salt-losing congenital adrenal hyperplasiaJAMA, 1982